Avidity Partners Management’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,265,545
| Closed | -$19.4M | – | 106 |
|
|
2023
Q1 | $19.4M | Sell |
1,265,545
-2,009,455
| -61% | -$30.8M | 0.64% | 51 |
|
|
2022
Q4 | $72.7M | Buy |
3,275,000
+675,000
| +26% | +$15M | 1.57% | 21 |
|
|
2022
Q3 | $42.5M | Buy |
2,600,000
+519,800
| +25% | +$8.49M | 0.86% | 36 |
|
|
2022
Q2 | $30.2M | Buy |
2,080,200
+35,200
| +2% | +$511K | 0.69% | 35 |
|
|
2022
Q1 | $37.8M | Buy |
2,045,000
+230,000
| +13% | +$4.25M | 0.79% | 37 |
|
|
2021
Q4 | $43.1M | Buy |
1,815,000
+170,000
| +10% | +$4.04M | 0.92% | 36 |
|
|
2021
Q3 | $40.5M | Buy |
+1,645,000
| New | +$40.5M | 0.9% | 37 |
|
|
2020
Q3 | – | Sell |
-234,814
| Closed | -$6.64M | – | 83 |
|
|
2020
Q2 | $6.64M | Buy |
+234,814
| New | +$6.64M | 0.43% | 51 |
|